Compared to the control diet, the ethanol diet resulted in a very significant increase in hepatic steatosis (perilipin 2 staining) and this was significantly less in the GLP-1R agonist-treated ethanol diet group (Fig. 1A, B). Here, GLP1R is linked to Hepatic steatosis.